Royalty Pharma (RPRX) Insider Trading & Ownership → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free rprx Stock Alerts $27.98 +0.16 (+0.58%) (As of 04:00 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Royalty Pharma (NASDAQ:RPRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.72%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$15.54 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$72.42 M Get RPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Royalty Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RPRX Insider Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Royalty Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/4/2024Rory B RiggsDirectorSell35,702$27.55$983,590.10 1/2/2024Rory B RiggsDirectorSell235,200$28.52$6,707,904.00 12/27/2023Avara Management LtdMajor ShareholderSell41,729$28.01$1,168,829.29 8/9/2023Terrance P CoyneCFOSell37,500$30.72$1,152,000.00 7/12/2023Terrance P CoyneCFOSell37,500$31.07$1,165,125.00 6/28/2023Pablo G LegorretaCEOBuy130,000$29.51$3,836,300.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/12/2023Pablo G LegorretaCEOBuy45,000$33.00$1,485,000.00 6/5/2023George W LloydEVPSell19,215$33.54$644,471.10 6/2/2023George W LloydEVPSell93,907$33.64$3,159,031.48 5/24/2023Pablo G LegorretaCEOBuy150,000$32.25$4,837,500.00 5/22/2023Rory B RiggsDirectorSell1,750,000$32.82$57,435,000.00 5/16/2023Pablo G LegorretaCEOBuy160,388$33.57$5,384,225.16 (Data available from 1/1/2013 forward) RPRX Insider Trading Activity - Frequently Asked Questions Who is on Royalty Pharma's Insider Roster? The list of insiders at Royalty Pharma includes 1978 Sicaf Sif S.A. - Gg St Gg, 1978 Sicaf Sif S.A. Gg, Avara Management Ltd, George W Lloyd, Henry A Fernandez, James F Reddoch, Mario Germano Giuliani, Marshall Urist, Pablo G Legorreta, Rory B Riggs, and Terrance P Coyne. Learn more on insiders at RPRX. What percentage of Royalty Pharma stock is owned by insiders? 18.72% of Royalty Pharma stock is owned by insiders. Learn more on RPRX's insider holdings. Which Royalty Pharma insiders have been buying company stock? The following insider purchased RPRX shares in the last 24 months: Pablo G Legorreta ($15,543,025.16). How much insider buying is happening at Royalty Pharma? Insiders have purchased a total of 485,388 RPRX shares in the last 24 months for a total of $15,543,025.16 bought. Which Royalty Pharma insiders have been selling company stock? The following insiders have sold RPRX shares in the last 24 months: 1978 Sicaf Sif S.A. - Gg St Gg ($21,706,007.30), 1978 Sicaf Sif S.A. Gg ($8,107,732.80), Avara Management Ltd ($1,168,829.29), George W Lloyd ($17,683,664.30), James F Reddoch ($14,393,000.00), Mario Germano Giuliani ($44,732,612.08), Marshall Urist ($2,807,893.22), Rory B Riggs ($79,415,556.01), and Terrance P Coyne ($4,914,670.00). How much insider selling is happening at Royalty Pharma? Insiders have sold a total of 5,179,031 Royalty Pharma shares in the last 24 months for a total of $194,929,965.00 sold. More Insider Trading Tools from MarketBeat Related Companies: The Carlyle Group Insider Buying Loews Insider Buying Synchrony Financial Insider Buying Northern Trust Insider Buying Corebridge Financial Insider Buying KE Insider Buying Brookfield Asset Management Insider Buying Everest Group Insider Buying Aegon Insider Buying TPG Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:RPRX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
